Drugs / Dimethylaminoethanol
Dimethylaminoethanol
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07477288 | Mar → Sep 2025 | skin atrophy | Hasanuddin University | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dimethylaminoethanol | “Dimethylaminoethanol 2%” NCT07477288 ↗ |
| Known as | DMAE | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07477288 ↗ |
| Known as | N,n-dimethylaminoethanol (dmae) | ChEMBL registry synonym — accepted as the source's own label CHEMBL1135 ↗ |
| Modality | Small molecule | — CHEMBL1135 ↗ |
| Route | Topical | “Participants apply a serum of GABA 3% and DMAE 2% followed by a cream containing Cysteamine 2.5% and Bakuchiol 1% to the face twice daily for 8 weeks. to the face twice daily...” NCT07477288 ↗ |